The post Scilex Finalizes $150M Bitcoin Investment in Datavault AI appeared on BitcoinEthereumNews.com. Key Points: Scilex completes a substantial Bitcoin investment in Datavault AI. Marks a shift for Scilex towards digital asset integration. Signals confidence in healthcare-oriented data solutions. Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets. This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors. Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval. DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm. “We are thrilled to secure this strategic investment from Scilex, which demonstrates strong cross-sector confidence in our data solutions for the healthcare and biotechnology verticals.” — Nathaniel Bradley, CEO, Datavault AI Bitcoin’s Role in Cross-Sector Biotech Investments Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments. According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened… The post Scilex Finalizes $150M Bitcoin Investment in Datavault AI appeared on BitcoinEthereumNews.com. Key Points: Scilex completes a substantial Bitcoin investment in Datavault AI. Marks a shift for Scilex towards digital asset integration. Signals confidence in healthcare-oriented data solutions. Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets. This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors. Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval. DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm. “We are thrilled to secure this strategic investment from Scilex, which demonstrates strong cross-sector confidence in our data solutions for the healthcare and biotechnology verticals.” — Nathaniel Bradley, CEO, Datavault AI Bitcoin’s Role in Cross-Sector Biotech Investments Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments. According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened…

Scilex Finalizes $150M Bitcoin Investment in Datavault AI

Key Points:
  • Scilex completes a substantial Bitcoin investment in Datavault AI.
  • Marks a shift for Scilex towards digital asset integration.
  • Signals confidence in healthcare-oriented data solutions.

Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets.

This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors.

Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq

Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval.

DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm.

Bitcoin’s Role in Cross-Sector Biotech Investments

Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments.

According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase.

Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap

Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened industry collaborations. Regulatory responses remain crucial, considering Bitcoin’s evolving role in diverse investments.

Source: https://coincu.com/news/scilex-bitcoin-investment-completion/

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Horror Thriller ‘Bring Her Back’ Gets HBO Max Premiere Date

Horror Thriller ‘Bring Her Back’ Gets HBO Max Premiere Date

The post Horror Thriller ‘Bring Her Back’ Gets HBO Max Premiere Date appeared on BitcoinEthereumNews.com. Jonah Wren Phillips in “Bring Her Back.” A24 Bring Her Back, a new A24 horror movie from the filmmakers of the smash hit Talk to Me, is coming soon to HBO Max. Bring Her Back opened in theaters on May 30 before debuting on digital streaming via premium video on demand on July 1. The official logline for Bring Her Back reads, “A brother and sister uncover a terrifying ritual at the secluded home of their new foster mother.” Forbes‘South Park’ Season 27 Updated Release Schedule: When Do New Episodes Come Out?By Tim Lammers Directed by twin brothers Danny Philippou and Michael Philippou, Bring Her Back stars Billy Barratt, Sora Wong, Jonah Wren Philips, Sally–Anne Upton, Stephen Philips, Mischa Heywood and Sally Hawkins. Warner Bros. Discovery announced on Wednesday that Bring Her Back will arrive on streaming on HBO Max on Friday, Oct. 3, and on HBO linear on Saturday, Oct. 4, at 8 p.m. ET. Prior to the debut of Bring Her Back on HBO on Oct. 4, the cable outlet will air the Philippou brothers’ 2022 horror hit Talk to Me. ForbesHit Horror Thriller ’28 Years Later’ Is New On Netflix This WeekBy Tim Lammers For viewers who don’t have HBO Max, the streaming platform offers three tiers: The ad-based tier costs $9.99 per month, while an ad-free tier is $16.99 per month. Additionally, an ad-free tier with 4K Ultra HD programming costs $20.99 per month. The Success Of ‘Talk To Me’ Weighed On The Minds Of Philippou Brothers While Making ‘Bring Her Back’ During the film’s theatrical run, Bring Her Back earned $19.3 million domestically and nearly $19.8 million internationally for a worldwide box office tally of $39.1 million. Bring Her Back had a production budget of $17 million before prints and advertising, according to The Numbers.…
Share
BitcoinEthereumNews2025/09/18 09:23
XRP Price Prediction: Inflows, Rising Open Interest, and ETF Momentum Put $2.75 in Focus

XRP Price Prediction: Inflows, Rising Open Interest, and ETF Momentum Put $2.75 in Focus

XRP gains traction with ETFs, tokenization, and $69.5M in inflows, reinforcing its institutional appeal amid shifting crypto dynamics.
Share
Blockchainreporter2026/01/22 22:20
Ubisoft stock hits multiple all-time lows after major restructuring and six game cancellations

Ubisoft stock hits multiple all-time lows after major restructuring and six game cancellations

The post Ubisoft stock hits multiple all-time lows after major restructuring and six game cancellations appeared on BitcoinEthereumNews.com. Ubisoft shares tanked
Share
BitcoinEthereumNews2026/01/22 22:01